Treatment beyond progression: is it moving from belief to evidence?
Yerushalmi
Rinat
R
Gelmon
Karen
K
D018450:Disease Progression; D023381:Endpoint Determination; D006801:Humans; D009369:Neoplasms / Q000201:enzymology / Q000473:pathology* / Q000628:therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors
D018719:Erb-b2 Receptor Tyrosine Kinases